Targeting Hsp90 for the treatment of cancer.

Drysdale, Martin J; Brough, Paul A; Massey, Andrew; Jensen, Michael Rugaard; Schoepfer, Joseph

Drysdale, Martin J; Brough, Paul A; Massey, Andrew; Jensen, Michael Rugaard; Schoepfer, Joseph.

Affiliation

Drysdale MJ; Vernalis Ltd, Granta Park, Great Abington, Cambridge, CB1 6GB, UK. m.drysdale@vernalis.com

Curr Opin Drug Discov Devel ; 9(4): 483-95, 2006 Jul.

Article in En | MEDLINE | ID: mdl-16889231

Subject(s)

Antineoplastic Agents/chemistry; Drug Delivery Systems/methods; HSP90 Heat-Shock Proteins/metabolism; Neoplasms/drug therapy; Animals; Antineoplastic Agents/administration & dosage; Binding Sites/drug effects; Binding Sites/physiology; Humans; Neoplasms/metabolism

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Drug Delivery Systems / HSP90 Heat-Shock Proteins / Neoplasms / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Curr Opin Drug Discov Devel Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2006 Type: Article Affiliation country: United kingdom

Search on Google

XML

PubMed Links